PNC Financial Services Group
ADMA icon

PNC Financial Services Group’s ADMA Biologics ADMA Stock Holding History

PNC Financial Services Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$128K Buy
12,807
+2,596
+25% +$24K ﹤0.01% 2799
2026
Q2 		$85.5K Sell
10,211
-2,729
-21% -$24.9K ﹤0.01% 3032
2026
Q1 		$117K Sell
12,940
-22,587
-64% -$356K ﹤0.01% 2704
2025
Q4 		$648K Sell
35,527
-7,963
-18% -$134K ﹤0.01% 1482
2025
Q3 		$638K Buy
43,490
+15,792
+57% +$271K ﹤0.01% 1494
2025
Q2 		$504K Buy
27,698
+4,373
+19% +$89.2K ﹤0.01% 1551
2025
Q1 		$463K Buy
23,325
+4,553
+24% +$78.7K ﹤0.01% 1572
2024
Q4 		$322K Buy
18,772
+2,279
+14% +$42.9K ﹤0.01% 1857
2024
Q3 		$330K Buy
16,493
+16,364
+12,685% +$254K ﹤0.01% 1832
2024
Q2 		$1.44K Buy
129
+95
+279% +$797 ﹤0.01% 4343
2024
Q1 		$224 Buy
34
+9
+36% +$49 ﹤0.01% 4597
2023
Q4 		$113 Buy
+25
New +$92 ﹤0.01% 4514
2021
Q3 		– Sell
-1,600
Closed -$2K – 4280
2021
Q2 		$2K Buy
+1,600
New +$2.82K ﹤0.01% 4011

Other funds holding ADMA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

PNC Financial Services Group's ADMA Position: Q3 2026 in Review

PNC Financial Services Group increased its ADMA Biologics (ADMA) stake by 25% in Q3 2026, buying an estimated $24K and bringing the position to 12,807 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #2799.

PNC Financial Services Group first reported a position in ADMA in Q2 2021 and has held it in 13 quarters since. The position peaked at $648K in Q4 2025. 262 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • PNC Financial Services Group held 12,807 shares of ADMA Biologics worth $128K as of Q3 2026.
  • PNC Financial Services Group bought 2,596 ADMA Biologics shares in Q3 2026, an estimated $24K.
  • ADMA Biologics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #2799 holding.
  • PNC Financial Services Group first reported a position in ADMA Biologics in Q2 2021 and has held it in 13 quarters since.
  • PNC Financial Services Group's ADMA Biologics position peaked at $648K in Q4 2025.
  • 262 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.